National Marrow Donor Program Executive and Leadership Team

Amy Ronneberg, the Chief Executive Officer at National Marrow Donor Program, directs the overarching strategic vision for the organization. Overseeing the transition to the NMDP brand, the Chief Executive Officer ensures alignment with long-term goals for cellular therapy access. This leadership role involves managing complex stakeholder relationships and driving organizational growth across North American and international markets. By optimizing operational efficiency, Amy Ronneberg directly impacts the ability to facilitate life-saving transplants for patients in need. Ronneberg maintains focus on scaling the registry to meet future medical demands while fostering innovation in donor recruitment. Ultimately, the Chief Executive Officer secures the financial and operational stability required to sustain the mission of connecting patients with compatible donors worldwide.

Jeffrey Chell, the Chief Executive Officer Emeritus at National Marrow Donor Program, provides high-level advisory support to the current leadership team. Leveraging extensive historical knowledge, the Chief Executive Officer Emeritus guides long-term strategic initiatives and maintains critical relationships with key medical partners. This role involves evaluating the evolution of cellular therapy standards to ensure the organization remains at the forefront of the industry. By offering deep institutional insight, Jeffrey Chell supports the transition toward modernized branding and expanded global reach. Chell assists in navigating complex regulatory landscapes and maintaining the integrity of the donor registry. Ultimately, the Chief Executive Officer Emeritus ensures continuity in the mission to save lives through consistent, expert guidance on organizational policy and strategic development.

Katherine Heyerdahl, the Chief Financial Officer at National Marrow Donor Program, manages the fiscal health and resource allocation for the entire organization. Overseeing financial planning, budgeting, and reporting, the Chief Financial Officer ensures the sustainability of life-saving programs. This leadership role involves analyzing market trends to optimize funding strategies and support long-term growth initiatives. By maintaining rigorous financial controls, Katherine Heyerdahl directly impacts the organization's ability to invest in new technologies and donor recruitment efforts. Heyerdahl works closely with the executive team to align fiscal priorities with the core mission of facilitating transplants. Ultimately, the Chief Financial Officer provides the economic foundation necessary for the organization to scale operations and meet the evolving needs of patients globally.

Komal Khoja, the President at National Marrow Donor Program, executes the operational strategy and day-to-day management of the organization. Overseeing key business units, the President ensures that internal processes align with the broader mission of facilitating life-saving transplants. This leadership role involves driving organizational performance and fostering collaboration across departments to achieve strategic objectives. By optimizing operational workflows, Komal Khoja directly impacts the efficiency of the donor matching process. Khoja works with the executive team to implement the modernized brand vision and expand the organization's reach in the cellular therapy market. Ultimately, the President maintains the operational momentum necessary to support the organization's ambitious future and ensure consistent delivery of services to patients and medical partners.

Jim Graham, the Chief Information Officer at National Marrow Donor Program, architects the digital infrastructure necessary for managing a global donor registry. Overseeing data integrity and system scalability, the Chief Information Officer ensures seamless connectivity between medical centers and potential donors. This leadership role involves implementing advanced software solutions to streamline the matching process and improve patient outcomes. By modernizing the technological framework, Jim Graham directly impacts the speed and accuracy of life-saving transplant coordination. Graham collaborates with cross-functional teams to integrate new digital tools that support the organization's ambitious future. Ultimately, the Chief Information Officer drives the technological transformation required to maintain a robust, secure, and highly responsive platform for cellular therapy operations.

Rob Hanson, the Vice President, Technology & Officer & Dpo Chief Technology Officer & Chief Information Security Officer at National Marrow Donor Program, secures the digital assets and data privacy of the donor registry. Overseeing cybersecurity protocols and technology compliance, the Vice President, Technology & Officer & Dpo Chief Technology Officer & Chief Information Security Officer ensures the protection of sensitive medical information. This leadership role involves implementing robust defense mechanisms against evolving cyber threats to maintain trust within the global medical community. By architecting secure systems, Rob Hanson directly impacts the reliability of the organization's digital infrastructure. Hanson coordinates with internal teams to enforce data protection standards across all operational platforms. Ultimately, the Vice President, Technology & Officer & Dpo Chief Technology Officer & Chief Information Security Officer safeguards the integrity of the entire transplant matching network.

Dennis Confer, the Chief Medical Officer at National Marrow Donor Program, directs the clinical standards and medical policies governing the donor registry. Overseeing the scientific integrity of transplant matching, the Chief Medical Officer ensures that all procedures meet the highest safety and efficacy benchmarks. This leadership role involves collaborating with medical institutions to advance cellular therapy research and clinical practice. By providing expert medical guidance, Dennis Confer directly impacts the success rates of life-saving transplants. Confer monitors emerging medical trends to adapt the organization's clinical strategies to the changing needs of patients. Ultimately, the Chief Medical Officer maintains the clinical excellence required to support the organization's mission of providing high-quality, reliable donor matches for patients worldwide.